Abstract:AbstractActive inflammation is an important feature of vulnerable plaques, and monocyte chemoattractant protein‐1 (MCP‐1) is a key chemokine that promotes monocyte–endothelium binding and initiates inflammation. We aimed to determine whether dominant‐negative mutation of MCP‐1 could reverse atherosclerotic lesion progression and prevent vulnerable plaques from rupture regardless of serum lipid levels. The mutant MCP‐1 was produced by deletion of the N‐terminal amino acids 2 to 8 (7ND), and a eukaryotic expression vector plRES‐EGFP‐7ND was constructed. The transwell chamber was used to assay chemotaxis of monocytes in vitro. Thirty New Zealand white rabbits underwent balloon‐induced abdominal aortic endothelial injury and were randomly divided into control group without gene intervention (group A, n = 10), plRES‐EGFP‐7ND treatment group (group B, n = 10) and empty vector treatment group (group C, n = 10). All rabbits were fed a diet of 1% cholesterol for 8 weeks, and then group A rabbits were killed, whereas groups B and C rabbits received an intramuscular injection of plRES‐EGFP‐7ND and an empty lipofectamine, respectively, and remained on a high cholesterol diet for 4 weeks. At the end of week 12, groups B and C rabbits underwent pharmacological triggering by injection with Chinese Russellis viper venom and histamine. Serum lipids and inflammatory markers were measured, and high‐frequency ultra‐sonography and intravascular ultrasound imaging were performed. Immunohistochemistry and RT‐PCR were used to examine expression of inflammatory markers in the plaques. In vitro transfection of plRES‐EGFP‐7ND resulted in a significant inhibition of monocyte chemotaxis (P < 0.05) and in vivo transfection of plRES‐EGFP‐7ND significantly increased the thickness of the fibrous caps and decreased plaque vulnerability index. The incidence of plaque rupture in group B was 0% as compared with 56% in the empty vector treatment group (P< 0.05). The serum levels and expression of inflammatory markers were significantly reduced in group B. In conclusion, PIRES‐EGFP‐7ND transfection effectively inhibits plaque inflammation, reverses plaque progression and prevents vulnerable plaques from rupture. These therapeutic effects are independent of serum lipid levels and demonstrate that inhibition of plaque inflammation alone without lipid lowering can stabilize vulnerable plaques.

Heme Oxygenase-1 Inhibits Progression and Destabilization of Vulnerable Plaques in a Rabbit Model of Atherosclerosis.

Heme Oxygenase-1 Inhibits Atherosclerosis Progression and Promotes Plaque Stability in a Rabbit Model

Haemin-enhanced expression of haem oxygenase-1 stabilizes erythrocyte-induced vulnerable atherosclerotic plaques

Effects of heme oxygenase-1 on MDA CD68 and MMP-9 in atherosclerotic rat

Effect of Heme Oxygenase-1 on Atherosclerosis in Rats

Probucol Protects Against Atherosclerosis Through Induction of Heme Oxygenase-1

Prolyl-4-hydroxylase- 1 Improves the Stability of Advanced Plaques but Accelerates the Atherosclerotic Lesion Formation of Early Plaques

Overexpression of Prolyl-4-Hydroxylase-α1 Stabilizes but Increases Shear Stress-Induced Atherosclerotic Plaque in Apolipoprotein E-Deficient Mice

Myeloperoxidase-oxidized High Density Lipoprotein Impairs Atherosclerotic Plaque Stability by Inhibiting Smooth Muscle Cell Migration

Effect of Adiponectin Overexpression on Stability of Preexisting Plaques by Inducing Prolyl-4-hydroxylase Expression.

Dominant‐negative Mutation of Monocyte Chemoattractant Protein‐1 Prevents Vulnerable Plaques from Rupture in Rabbits Independent of Serum Lipid Levels

Endogenous Activated Angiotensin-(1-7) Plays A Protective Effect Against Atherosclerotic Plaques Unstability in High Fat Diet Fed Apoe Knockout Mice

Silencing of Non-POU-domain-containing Octamer-Binding Protein Stabilizes Atherosclerotic Plaque in Apolipoprotein E-knockout Mice Via NF-κB Signaling Pathway.

Role of CD163/HO-1 Pathway Activation in Stabilizing Atherosclerosis Vulnerable Plaque

Ginsenoside Rb-1 Enhances Plaque Stability And Inhibits Adventitial Vasa Vasorum Via The Modulation Of Mir-33 And Pedf

HO-1 Nuclear Accumulation and Interaction with NPM1 Protect Against Stress-Induced Endothelial Senescence Independent of Its Enzymatic Activity

Ginsenoside Rb1 Enhances Plaque Stability and Inhibits Adventitial Vasa Vasorum via the Modulation of miR-33 and PEDF

Haem Oxygenase-1 Inhibits Neointimal Hyperplasia in Rat by Histone Deacetylase 2.

Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques.

Poly (Adp-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in Apoe-/- Mice with Hyperhomocysteinemia

Studies on Protective Effects of Human Paraoxonases 1 and 3 on Atherosclerosis in Apolipoprotein E Knockout Mice.